Journal Mobile Options
Table of Contents
Vol. 21, No. 1, 2006
Issue release date: December 2005
Dement Geriatr Cogn Disord 2006;21:16–21

Relationship between Delusions and Regional Cerebral Blood Flow in Alzheimer’s Disease

Nakano S. · Yamashita F. · Matsuda H. · Kodama C. · Yamada T.
aDepartment of Internal Medicine, Fukuoka University, Fukuoka, bNational Center of Neurology and Psychiatry (NCNP), Musashi Hospital,Tokyo, and cDepartment of Nuclear Medicine, Saitama Medical School Hospital, Saitama, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


To investigate the association between delusions and cerebral functional deficits in Alzheimer’s disease (AD), we evaluated probable AD patients with and without delusions. Methods: Functional brain imaging was performed by single photon emission computed tomography with technetium-99m-labeled ethyl cysteinate dimer (99mTc-ECD) in 64 AD patients and 76 age-matched normal healthy volunteers. SPECT data were analyzed by statistical parametric mapping. Results: In AD patients, no differences were found in age and cognitive activities between those with (n = 25) and without (n = 39) delusions. Compared with normal healthy volunteers, AD patients had significantly decreased perfusion in the posterior cingulate gyri, precunei, and parietal association cortex. Moreover, in the patients with delusions, perfusion was significantly decreased in the frontal lobe with right side dominance. In the comparison between the patients with and without delusions, the patients with delusions had significantly decreased perfusion in the prefrontal cortex, anterior cingulate gyri, inferior to middle temporal cortices, and parietal cortex of the right hemisphere (p < 0.01). Conclusion: The functional deficits in the right hemisphere may be the cause of delusions in AD.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Psychotic symptoms in Alzheimer’s disease (editorial). Lancet 1989;ii:1193–1194.
  2. Rabins PV, Mace NL, Lucas MJ: The impact of dementia on the family. JAMA 1982;248:333–335.
  3. Haupt M, Romero B, Kurz A: Delusions and hallucinations in Alzheimer’s disease: results from two-year longitudinal study. Int J Geriatr Psychiatry 1996;11:965–972.

    External Resources

  4. Steele C, Rovner B, Chase GA, Folstein M: Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry 1990;147:1049–1051.
  5. Haupt M, Kurz A: Predictors of nursing home placement in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 1993;8:741–746.

    External Resources

  6. Ikeda M, Shigenobu K, Fukuhara R, Hokoishi K, Nebu A, Maki N, Nomura M, Komori K, Tanabe H: Delusions of Japanese patients with Alzheimer’s disease. Int J Geriatr Psychiatry 2003;18:527–532.
  7. Hirono N, Mori E, Ishii K, Kitagaki H, Sasaki M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Yamashita H: Alteration of regional cerebral glucose utilization with delusions in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1998;10:433–439.
  8. Starkstein SE, Vazquez S, Petracca G, Sabe L, Migliorelli R, Teson A, Leiguarda R: A SPECT study of delusions in Alzheimer’s disease. Neurology 1994;44:2055–2059.
  9. Staff RT, Shanks MF, Macintosh L, Pestell SJ, Gemmell HG, Venneri A: Delusions in Alzheimer’s disease: spet evidence of right hemispheric dysfunction. Cortex 1999;35:549–560.
  10. Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL: Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2000;69:167–171.
  11. Sultzer DL, Brown CV, Mandelkern MA, Mahler ME, Mendez MF, Chen ST, Cummings JL: Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer’s disease. Am J Psychiatry 2003;160:341–349.
  12. Mentis MJ, Weinstein EA, Horwitz B, McIntosh AR, Pietrini P, Alexander GE, Furey M, Murphy DG: Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biol Psychiatry 1995;38:438–449.
  13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA working group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  14. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  15. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  16. Imabayashi E, Matsuda H, Asada T, Ohnishi T, Sakamoto S, Nakano S, Inoue T: Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer’s disease from controls using brain perfusion SPECT. J Nucl Med 2004;45:1450–1457.
  17. Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, Sasaki M: Abnormal regional cerebral blood flow in childhood autism. Brain 2000;123:1838–1844.
  18. Migliorelli R, Petracca G, Teson A, Sabe L, Leiguarda R, Starkstein SE: Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer’s disease. Psychol Med 1995;25:505–513.
  19. Alzheimer A: İber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psych-Gerichtl Med 1907;64:146–148.
  20. Mega MS, Cummings JL, Fiorello T, Gornbein J: The spectrum of behavioral changes in Alzheimer’s disease. Neurology 1996;46:130–135.
  21. Ozawa I: The delusion of theft in elderly with dementia.1. Statistical data and psychopathology of the delusion (in Japanese). Seishin Shinkeigaku Zasshi 1997;99:370–388.
  22. Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H: Factors associated with psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1998;64:648–652.
  23. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA: Hallucinations, delusions, and cognitive decline in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2000;69:172–177.
  24. Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG: Delusions and hallucinations in Alzheimer’s disease: prevalence and clinical correlates. Int J Geriatr Psychiatry 2000;15:99–107.
  25. Minoshima S, Foster NL, Kuhl DE: Posterior cingulate cortex in Alzheimer’s disease. Lancet 1994;344:895.
  26. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 1997;42:85–94.
  27. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E: Demonstration of decreased posterior cingulate perfusion in mild Alzheimer’s disease by means of H215O positron emission tomography. Eur J Nucl Med 1997;24:670–673.
  28. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M: Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT. J Nucl Med 2000;41:1155–1162.
  29. Malloy PF, Richardson ED: The frontal lobes and content-specific delusions. J Neuropsychiatry Clin Neurosci 1994;6:455–466.
  30. Fukuhara R, Ikeda M, Nebu A, Kikuchi T, Maki N, Hokoishi K, Shigenobu K, Komori K, Tanabe H: Alteration of rCBF in Alzheimer’s disease patients with delusions of theft. Neuroreport 2001;12:2473–2476.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50